Resultats de la cerca - Richard Elliott
- Mostrar 1 - 20 resultats de 24
- Anar a la pàgina següent
-
1
Existential consumption and irrational desire per Richard Elliott
Publicat 1997Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways per Marieke Aarts, Ilirjana Bajrami, María Teresa Herrera-Abreu, Richard Elliott, Rachel Brough, Alan Ashworth, Christopher J. Lord, Nicholas C. Turner
Publicat 2015Artigo -
10
BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency per Yuqiao Shen, Farah Rehman, Ying Feng, Julia Boshuizen, Ilirjana Bajrami, Richard Elliott, Bing Wang, Christopher J. Lord, Leonard Post, Alan Ashworth
Publicat 2013Artigo -
11
Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer per Elizabeth Iorns, Nicholas C. Turner, Richard Elliott, Nelofer Syed, Ornella Garrone, Milena Gasco, Andrew Tutt, Tim Crook, Christopher J. Lord, Alan Ashworth
Publicat 2008Artigo -
12
-
13
Inactivation of Effector Caspases through Nondegradative Polyubiquitylation per Mark Ditzel, Meike Broemer, Tencho Tenev, Clare Bolduc, Tom V. Lee, Kristoffer T. G. Rigbolt, Richard Elliott, Marketa Zvelebil, Blagoy Blagoev, Andreas Bergmann, Pascal Meier
Publicat 2008Artigo -
14
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours per Neil Rajan, Richard Elliott, Oliver Clewes, Alan Mackay, Jorge S. Reis‐Filho, John Burn, J.A.A. Langtry, Maya Sieber‐Blum, Christopher J. Lord, A. Ashworth
Publicat 2011Artigo -
15
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer per Sophie Postel‐Vinay, Ilirjana Bajrami, Luc Friboulet, Richard Elliott, Yari Fontebasso, Nicolas Dorvault, Ken A. Olaussen, Fabrice André, J.C. Soria, Christopher J. Lord, Alan Ashworth
Publicat 2013Artigo -
16
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks per Elaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, Lynne Belle‐Isle, Richard Elliott, Bernie Pauly, Carol Strike, Mark Asbridge, Colleen Anne Dell, Keely McBride, Andrew D. Hathaway, T. Cameron Wild
Publicat 2017Artigo -
17
Discovery of senolytics using machine learning per Vanessa Smer-Barreto, Andrea Quintanilla, Richard Elliott, John C. Dawson, Jiugeng Sun, Víctor M. Campa, Álvaro Lorente‐Macías, Asier Unciti‐Broceta, Neil O. Carragher, Juan Carlos Acosta, Diego A. Oyarzún
Publicat 2023Artigo -
18
Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer’s disease per Amina McDiarmid, Katerina Gospodinova, Richard Elliott, John C. Dawson, Rebecca E. Graham, Marie‐Thérèse El‐Daher, Susan M. Anderson, Sophie Glen, Simon Glerup, Neil O. Carragher, Kathryn L. Evans
Publicat 2024Artigo -
19
Public support for harm reduction: A population survey of Canadian adults per T. Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, Mark Asbridge, Lynne Belle‐Isle, Colleen Anne Dell, Richard Elliott, Andrew D. Hathaway, Donald MacPherson, Keely McBride, Bernie Pauly, Carol Strike, Adam M. Galovan, Elaine Hyshka
Publicat 2021Artigo -
20
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors per Malini Menon, Richard Elliott, Leandra Bowers, Nicolae Balan, Rumana Rafiq, Sara Costa-Cabral, Felix M. Munkonge, Ines Trinidade, Roderick A. Porter, Andrew D. Campbell, Emma Johnson, Christina Esdar, Hans‐Peter Buchstaller, Birgitta Leuthner, Felix Rohdich, Richard Schneider, Owen J. Sansom, Dirk Wienke, Alan Ashworth, Christopher J. Lord
Publicat 2019Artigo
Eines de cerca:
Matèries relacionades
Biology
Medicine
Cancer research
Genetics
Cancer
Cell biology
Gene
Law
Political science
Biochemistry
Internal medicine
Computer science
DNA
DNA repair
Nursing
Pathology
Pharmacology
Public health
Bioinformatics
Breast cancer
Cell cycle
Chemistry
DNA damage
Drug
Drug discovery
Gene silencing
Human immunodeficiency virus (HIV)
Kinase
Molecular biology
PARP inhibitor